The development of better biopsy approaches is driven by the fact that lung cancer kills more than 130,000 Americans annually, and survival depends on early diagnosis, which requires biopsy to be definitive.
Lung cancer is the leading cause of cancer death in the United States, with incidence higher in veterans compared to the civilian population.
Study showed that the improvement in lung cancer screenings exceeded the target enrollment set by the researchers.
Prior research has shown that Americans of African ancestry have a higher risk of lung cancer compared to white Americans despite smoking fewer cigarettes, but the reasons for this difference are not fully understood.
Each year, millions of lung nodules are detected during routine X-rays or CT scans.
VUMC researchers tested a treatment combining immunotherapy and online adaptive radiotherapy, which is tailored to real-time tumor changes during the treatment plan.